SyntheX
Maria Soloveychik is the co-founder and CEO of SyntheX, Inc., where Maria leads the development of intracellular selection platforms for discovering molecules targeting undruggable proteins in oncology. Previously, Maria was a doctoral student at the University of Toronto, focusing on epigenetic mechanisms of gene expression and cell metabolism. Maria also worked as a consultant at SCIENCESCAPE and held leadership roles at the Molecular Genetics Graduate Students' Association. With a Ph.D. in Molecular Genetics and a Bachelor's Degree in Molecular Genetics and Microbiology, Maria has a strong background in research and protein optimization.